KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Prepaid Assets (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Prepaid Assets for 17 consecutive years, with $27.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 9.77% to $27.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.7 million, a 9.77% decrease, with the full-year FY2025 number at $27.7 million, down 9.77% from a year prior.
  • Prepaid Assets was $27.7 million for Q4 2025 at Bio-Rad Laboratories, down from $152.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $153.0 million in Q2 2024 to a low of $10.1 million in Q4 2021.
  • A 5-year average of $70.2 million and a median of $30.7 million in 2024 define the central range for Prepaid Assets.
  • Biggest YoY gain for Prepaid Assets was 2007.13% in 2021; the steepest drop was 88.87% in 2021.
  • Bio-Rad Laboratories' Prepaid Assets stood at $10.1 million in 2021, then skyrocketed by 133.96% to $23.6 million in 2022, then soared by 493.12% to $140.0 million in 2023, then plummeted by 78.07% to $30.7 million in 2024, then decreased by 9.77% to $27.7 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Prepaid Assets are $27.7 million (Q4 2025), $152.0 million (Q3 2025), and $19.0 million (Q2 2025).